Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis

Cancer Trials Versus the Real World in the United States

(2011) Waddah B. Al-Refaie et al.   ANNALS OF SURGERY

Dual HER2-targeted approaches in HER2-positive breast cancer

(2011) Eugene R. Ahn et al.   BREAST CANCER RESEARCH AND TREATMENT

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

(2011) Dennis Slamon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation

(2010) Daniela Cardinale et al.   JOURNAL OF CLINICAL ONCOLOGY

HER2-ASCO-Guidelines

(2010) E. Burandt et al.   PATHOLOGE

Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer

(2009) Xianglin L. Du et al.   CANCER

Trastuzumab-Induced Cardiomyopathy: Not as Benign as it Looks? A Retrospective Study

(2009) Maya Guglin et al.   JOURNAL OF CARDIAC FAILURE

Can Heart Failure Medications Prevent Trastuzumab-Induced Cardiotoxicity?

(2009) Christopher C. Reynolds et al.   JOURNAL OF CARDIAC FAILURE

Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

(2009) Heikki Joensuu et al.   JOURNAL OF CLINICAL ONCOLOGY

Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations

(2008) C. Hery et al.   ANNALS OF ONCOLOGY

Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study

(2008) Deepa Wadhwa et al.   BREAST CANCER RESEARCH AND TREATMENT

Cardiac Management During Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group

(2008) John Mackey   Current Oncology

Cardiotoxicity Profile of Trastuzumab

(2008) Steven M Ewer et al.   DRUG SAFETY